Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers

被引:193
作者
Izukawa, Takeshi [1 ]
Nakajima, Miki [1 ]
Fujiwara, Ryoichi [1 ]
Yamanaka, Hiroyuki [1 ]
Fukami, Tatsuki [1 ]
Takamiya, Masataka [2 ]
Aoki, Yasuhiro [2 ]
Ikushiro, Shin-ichi [3 ]
Sakaki, Toshiyuki [3 ]
Yokoi, Tsuyoshi [1 ]
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
[2] Iwate Med Univ, Sch Med, Dept Legal Med, Morioka, Iwate 020, Japan
[3] Toyama Prefectural Univ, Fac Engn, Biotechnol Res Ctr, Toyama, Japan
关键词
HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; MESSENGER-RNA; DELETION POLYMORPHISM; GENETIC POLYMORPHISMS; GLUCURONIDATION; IDENTIFICATION; ASSOCIATION; PROMOTER; DISEASE; CANCER;
D O I
10.1124/dmd.109.027227
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferases (UGTs) catalyze glucuronidation of a variety of xenobiotics and endobiotics. UGTs are divided into two families, UGT1 and UGT2. The purpose of this study was to estimate the absolute expression levels of each UGT isoform in human liver and to evaluate the interindividual variability. Real-time reverse transcriptase-polymerase chain reaction analysis was performed to determine the copy numbers of nine functional UGT1A isoforms and seven UGT2B isoforms. We noticed that not only primers but also templates as a standard for quantification should prudently be selected. Once we established appropriate conditions, the mRNA levels of each UGT isoform in 25 individual human livers were determined. UGT1A1 (0.9-138.5), UGT1A3 (0.1-66.6), UGT1A4 (0.1-143.3), UGT1A6 (1.0-70.4), UGT1A9 (0.3-132.4), UGT2B4 (0.3-615.0), UGT2B7 (0.2-97.4), UGT2B10 (0.7-253.2), UGT2B15 (0.3-107.8), and UGT2B17 (0.5-157.1) were substantially expressed (x10(4) copy/mu g RNA) with large interindividual variability. Abundant isoforms were UGT2B4 and UGT2B10, followed by UGT1A1, UGT2B15, and UGT1A6. The sum of the UGT2B mRNA levels was higher than that of UGT1A mRNA levels. It is interesting to note that the mRNA levels normalized with glyceraldehyde-3-phosphate dehydrogenase mRNA for almost UGT isoforms that are substantially expressed in liver showed significant correlations to each other. Western blot analysis was performed using antibodies specific for UGT1A1, UGT1A4, UGT1A6, or UGT2B7. Correlation between the protein and mRNA levels was observed in only UGT1A1 (r = 0.488; p < 0.01). In conclusion, this study comprehensively determined the absolute values of mRNA expression of each UGT isoform in human livers and found considerable interindividual variability.
引用
收藏
页码:1759 / 1768
页数:10
相关论文
共 36 条
[1]   Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers [J].
Aueviriyavit, Sasitorn ;
Furihata, Tomomi ;
Morimoto, Kaori ;
Kobayashi, Kaoru ;
Chiba, Kan .
DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (05) :391-398
[2]   Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4α [J].
Barbier, O ;
Girard, H ;
Inoue, Y ;
Duez, H ;
Villeneuve, L ;
Kamiya, A ;
Fruchart, JC ;
Guillemette, C ;
Gonzalez, FJ ;
Staels, B .
MOLECULAR PHARMACOLOGY, 2005, 67 (01) :241-249
[3]   Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11 [J].
Beaulieu, M ;
Lévesque, E ;
Hum, DW ;
Bélanger, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (01) :44-50
[4]   Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1 [J].
Bernard, P ;
Goudonnet, H ;
Artur, Y ;
Desvergne, B ;
Wahli, W .
MOLECULAR PHARMACOLOGY, 1999, 56 (03) :526-536
[5]   UDP glucuronosyltransferase mRNA levels in human liver disease [J].
Congiu, M ;
Mashford, ML ;
Slavin, JL ;
Desmond, PV .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (02) :129-134
[6]   Novel polymorphic human UDP-glucuronosyltransferase 2A3: Cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction [J].
Court, Michael H. ;
Hazarika, Suwagmani ;
Krishnaswamy, Soundararajan ;
Finel, Moshe ;
Williams, J. Andrew .
MOLECULAR PHARMACOLOGY, 2008, 74 (03) :744-754
[7]   Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene [J].
Erichsen, Thomas J. ;
Ehmer, Ursula ;
Kalthoff, Sandra ;
Lankisch, Tim O. ;
Mueller, Tordis M. ;
Munzel, Peter A. ;
Manns, Michael P. ;
Strassburg, Christian R. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 230 (02) :252-260
[8]   Human UDP-Glucuronosyltransferase 1A5: Identification, expression, and activity [J].
Finel, M ;
Li, X ;
Gardner-Stephen, D ;
Bratton, S ;
Mackenzie, PI ;
Radominska-Pandya, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1143-1149
[9]   The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism [J].
Fisher, MB ;
Paine, MF ;
Strelevitz, TJ ;
Wrighton, SA .
DRUG METABOLISM REVIEWS, 2001, 33 (3-4) :273-297
[10]   Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms [J].
Fujiwara, Ryoichi ;
Nakajima, Miki ;
Yamanaka, Hiroyuki ;
Nakamura, Akiko ;
Katoh, Miki ;
Ikushiro, Shin-ichi ;
Sakaki, Toshiyuki ;
Yokoi, Tsuyoshi .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (05) :747-757